Jeffrey Aronin is the founder of Emalex Biosciences. Emalex Biosciences has raised $285M in total funding. Latest round: Series D.
Jeffrey Aronin is the founder and CEO of Emalex Biosciences, a biopharmaceutical company focused on developing therapies for Tourette syndrome. He previously founded and served as CEO of Paragon Biosciences, which played a key role in Emalex's funding.
Full founder directory · Investor directory · Company funding database · Fundraising library